Please login to the form below

Not currently logged in
Email:
Password:

Tamiflu

This page shows the latest Tamiflu news and features for those working in and with pharma, biotech and healthcare.

Long-serving R&D head Bischofberger to leave Gilead

Long-serving R&D head Bischofberger to leave Gilead

Austria-born Bischofberger - who rose to prominence as one of the inventors of Roche’s big-selling influenza drug Tamiflu (oseltamivir) - will leave the company fully in July after 28 years

Latest news

  • The state of trust The state of trust

    Roche has a mixed background in this area. Its reticence over publishing clinical studies for its flu drug Tamiflu was one of the drivers behind the formation of AllTrials in 2013.

  • Tecentriq growth offsets Avastin's US decline at Roche Tecentriq growth offsets Avastin's US decline at Roche

    Roche is expecting some pressure in 2017 thanks in part to the loss of US patent protection for influenza drug Tamiflu (oseltamivir) in December 2016, exposing around $500m of the

  • Cancer drugs help Roche beat expectations in first quarter Cancer drugs help Roche beat expectations in first quarter

    There was also a strong contribution from Roche's influenza drug Tamiflu (oseltamivir), which performed much better than expected with sales of CHF367m in the quarter.

  • AZ's influenza drug fast tracked in US AZ's influenza drug fast tracked in US

    While neuraminidase inhibitor therapies such as Roche's oral Tamiflu (oseltamivir) and GlaxoSmithKline's inhaled Relenza (zanamivir) have been available for years, but are recognised to have limited effectiveness, generally just ... MEDI8852 is currently

  • BioCryst gets FDA nod for first intravenous flu drug BioCryst gets FDA nod for first intravenous flu drug

    Rapivab is the third neuraminidase inhibitor to reach the market in the US after Roche's orally-active Tamiflu (oseltamivir) and GlaxoSmithKline's Relenza (zanamivir), which had sales of 452m Swiss

More from news
Approximately 9 fully matching, plus 94 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...
Light_bulb_Stock_Market.jpg
Creativity has lost its worth
Creativity has lost its worth, and sadly it is undermining effectiveness...

Infographics